239 results on '"Virzì, Grazia Maria"'
Search Results
2. Poly(lipoic acid)-based nanoparticles as a new therapeutic tool for delivering active molecules
3. Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review.
4. Remote monitoring in peritoneal dialysis: benefits on clinical outcomes and on quality of life
5. Peritoneal Inflammation in PD-Related Peritonitis Induces Systemic Eryptosis: In Vitro and In Vivo Assessments.
6. Immunomodulation Driven by Theranova Filter during a Single HD Session.
7. Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1
8. Catheter-related infections in peritoneal dialysis: comparison of a single center results and the literature data
9. Ongoing Peritoneal Dialysis Training at Home Allows for the Improvement of Patients' Empowerment: A Single Center Experience.
10. Scheduling of Remote Monitoring for Peritoneal Dialysis Patients.
11. Validation of peritoneal neutrophil gelatinase-associated lipocalin as a biomarker for peritonitis: A comparison between laboratory-base method and rapid stick test.
12. Contrast-Induced Encephalopathy: A Rare Complication in a Patient on Peritoneal Dialysis with Several Risk Factors.
13. The Cytotoxic Effect of Septic Plasma on Healthy RBCs: Is Eryptosis a New Mechanism for Sepsis?
14. Plasma Cell-Free DNA and Caspase-3 Levels in Patients with Chronic Kidney Disease.
15. Cellular apoptosis in the cardiorenal axis
16. Peritoneal Cell-free DNA: an innovative method for determining acute cell damage in peritoneal membrane and for monitoring the recovery process after peritonitis
17. New Frontiers in Diagnosis and Prevention of Acute Kidney Injury (AKI): The Role of Dendritic Cells and Innovative High-Throughput Techniques.
18. Eryptosis in Patients with Chronic Kidney Disease: A Possible Relationship with Oxidative Stress and Inflammatory Markers.
19. Eryptosis in Peritoneal Dialysis-Related Peritonitis: The Potential Role of Inflammation in Mediating the Increase in Eryptosis in PD.
20. The Role of Congestion in Cardiorenal Syndrome Type 2: New Pathophysiological Insights into an Experimental Model of Heart Failure
21. Cardiorenal Syndrome Type 1: Activation of Dual Apoptotic Pathways
22. Cardiorenal Syndrome Type 1: A Defective Regulation of Monocyte Apoptosis Induced by Proinflammatory and Proapoptotic Factors
23. Peritoneal Vicenza "Short" Catheter Outcomes and Comparison with International Society for Peritoneal Dialysis Guidelines.
24. In Vitro Induction of Eryptosis by Uremic Toxins and Inflammation Mediators in Healthy Red Blood Cells.
25. Analisi di Melt ad alta risoluzione (High Resolution Melt Analysis, HRMA): nuovo metodo di screening per il gene PKD2 in famiglie con malattia autosomica dominante del rene policistico
26. The Hemodynamic and Nonhemodynamic Crosstalk in Cardiorenal Syndrome Type 1
27. High-Resolution Melt as a Screening Method in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
28. Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Peritoneal Dialytic Effluent: Preliminary Results on the Comparison between Two Different Methods in Patients with and without Peritonitis.
29. Subclinical AKI and Clinical Outcomes in Elderly Patients Undergoing Cardiac Surgery: Diagnostic Utility of NGAL versus Standard Creatinine Increase Criteria.
30. Cardiorenal Syndrome Type 4: A Review
31. Heart–kidney crosstalk and role of humoral signaling in critical illness
32. Cardiorenal Syndrome Type 1 May Be Immunologically Mediated: A Pilot Evaluation of Monocyte Apoptosis
33. The Role of Cell-Free Plasma DNA in Patients with Cardiorenal Syndrome Type 1.
34. Lipopolysaccharide Evaluation in Peritoneal Dialysis Patients with Peritonitis.
35. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography.
36. Plasma Lipopolysaccharide Concentrations in Cardiorenal Syndrome Type 1.
37. Neurohormonal, Endocrine, and Immune Dysregulation and Inflammation in Cardiorenal Syndrome.
38. Eryptosis Is Altered in Peritoneal Dialysis Patients.
39. Multi-Omics Approach: New Potential Key Mechanisms Implicated in Cardiorenal Syndromes.
40. Persistent decrease of renal functional reserve in patients after cardiac surgery-associated acute kidney injury despite clinical recovery.
41. Direct Effect of Septic Plasma in Human Cell Lines Viability.
42. Presepsin and Procalcitonin Levels as Markers of Adverse Postoperative Complications and Mortality in Cardiac Surgery Patients.
43. Remote Patient Management in Peritoneal Dialysis Improves Clinical Outcomes.
44. Levels of Proinflammatory Cytokines, Oxidative Stress, and Tissue Damage Markers in Patients with Acute Heart Failure with and without Cardiorenal Syndrome Type 1.
45. Determinants of Monocyte Apoptosis in Cardiorenal Syndrome Type 1.
46. Perfluorocarbon solutions limit tubular epithelial cell injury and promote CD133+ kidney progenitor differentiation: potential use in renal assist devices for sepsis-associated acute kidney injury and multiple organ failure.
47. Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes.
48. Remote Monitoring of Automated Peritoneal Dialysis Improves Personalization of Dialytic Prescription and Patient’s Independence.
49. The Role of Dendritic and Endothelial Cells in Cardiorenal Syndrome.
50. Preoperative Renal Functional Reserve Predicts Risk of Acute Kidney Injury After Cardiac Operation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.